JSPP-12-01: A Point Prevalence Study to Evaluate the Prevalence of Antibodies to Selected Porcine Viruses in Patients with Cystic Fibrosis Who Are Receiving Porcine-Derived Pancreatic Enzyme Replacement Therapy: A Harmonized Pr

Project: Research project

Project Details

Effective start/end date2/3/1412/31/16


  • Registrat, Inc. (JSPP-12-01 VTPP)
  • AbbVie, Inc., Aptalis Pharma U.S., Inc., Janssen Research & Development LLC (JSPP-12-01 VTPP)